Aminov Erez

Chief Executive Officer, DirectorMIRA PHARMACEUTICALS, INC. (MIRA) · full profile →Form 4 · filed May 22, 2024
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 21, 2024Buy(P)600$0.87$522381K
May 21, 2024Buy(P)800$1.01$808381K
May 21, 2024Buy(P)2K$1.00$2K376K
May 21, 2024Buy(P)500$1.02$510377K
May 21, 2024Buy(P)1K$1.03$1K377K
May 21, 2024Buy(P)800$0.97$776382K
May 21, 2024Buy(P)2K$0.84$2K379K
May 21, 2024Buy(P)1K$0.85$850380K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-021069) within minutes of acceptance. Every field above traces to the original document. Verify it directly: